Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | Blcap (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of BLCAP mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | affects expression | ISO | Blcap (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of BLCAP mRNA | CTD | PMID:17555576 | 17alpha-ethynylestradiol | increases expression | ISO | Blcap (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of BLCAP mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | multiple interactions | ISO | Blcap (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BLCAP mRNA | CTD | PMID:17942748 | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | EXP | | 6480464 | Metribolone results in increased expression of BLCAP mRNA | CTD | PMID:17010196 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Blcap (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BLCAP mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Blcap (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BLCAP mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Blcap (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of BLCAP mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Blcap (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BLCAP mRNA | CTD | PMID:19770486 | 2,4-dinitrotoluene | affects expression | ISO | Blcap (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of BLCAP mRNA | CTD | PMID:21346803 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Blcap (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of BLCAP mRNA | CTD | PMID:20188158 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Blcap (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of BLCAP mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Blcap (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of BLCAP mRNA | CTD | PMID:36041667 | 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | Decitabine inhibits the reaction [aristolochic acid I results in decreased expression of BLCAP mRNA] and Decitabine inhibits the reaction [aristolochic acid I results in decreased expression of BLCAP protein] | CTD | PMID:29655784 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of BLCAP mRNA | CTD | PMID:21641981 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of BLCAP mRNA | CTD | PMID:23724009 | ammonium chloride | affects expression | ISO | Blcap (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of BLCAP mRNA | CTD | PMID:16483693 | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of BLCAP mRNA | CTD | PMID:33212167 | aristolochic acid A | multiple interactions | EXP | | 6480464 | decitabine inhibits the reaction [aristolochic acid I results in decreased expression of BLCAP mRNA] and decitabine inhibits the reaction [aristolochic acid I results in decreased expression of BLCAP protein] | CTD | PMID:29655784 | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of BLCAP mRNA and aristolochic acid I results in decreased expression of BLCAP protein | CTD | PMID:29655784 | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of BLCAP gene | CTD | PMID:25304211 | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of BLCAP gene | CTD | PMID:25304211 | azoxystrobin | decreases expression | EXP | | 6480464 | azoxystrobin results in decreased expression of BLCAP mRNA | CTD | PMID:33512557 | benzene | decreases expression | ISO | Blcap (Mus musculus) | 6480464 | Benzene results in decreased expression of BLCAP mRNA | CTD | PMID:15120971 | benzo[a]pyrene | multiple interactions | ISO | Blcap (Mus musculus) | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of BLCAP mRNA] | CTD | PMID:22228805 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of BLCAP 5' UTR and Benzo(a)pyrene affects the methylation of BLCAP promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of BLCAP mRNA | CTD | PMID:20106945 and PMID:21632981 | bisphenol A | increases expression | ISO | Blcap (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of BLCAP mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | ISO | Blcap (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of BLCAP mRNA | CTD | PMID:36041667 | bisphenol F | multiple interactions | ISO | Blcap (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of BLCAP mRNA | CTD | PMID:36041667 | chlorpyrifos | increases expression | ISO | Blcap (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of BLCAP mRNA | CTD | PMID:37019170 | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of BLCAP mRNA | CTD | PMID:19561079 and PMID:27392435 | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of BLCAP mRNA | CTD | PMID:27392435 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of BLCAP mRNA | CTD | PMID:25562108 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BLCAP mRNA | CTD | PMID:27188386 | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of BLCAP mRNA | CTD | PMID:29803840 | endosulfan | increases expression | ISO | Blcap (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of BLCAP mRNA | CTD | PMID:29391264 | epoxiconazole | decreases expression | ISO | Blcap (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of BLCAP mRNA | CTD | PMID:35436446 | ethanol | affects splicing | ISO | Blcap (Mus musculus) | 6480464 | Ethanol affects the splicing of BLCAP mRNA | CTD | PMID:30319688 | ethyl methanesulfonate | increases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in increased expression of BLCAP mRNA | CTD | PMID:23649840 | flavonoids | decreases expression | ISO | Blcap (Rattus norvegicus) | 6480464 | Flavonoids results in decreased expression of BLCAP mRNA | CTD | PMID:18035473 | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of BLCAP mRNA | CTD | PMID:23649840 | gentamycin | decreases expression | ISO | Blcap (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of BLCAP mRNA | CTD | PMID:33387578 | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of BLCAP mRNA | CTD | PMID:28988120 | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of BLCAP mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of BLCAP mRNA | CTD | PMID:28001369 | ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of BLCAP mRNA | CTD | PMID:22124623 | paracetamol | affects expression | ISO | Blcap (Mus musculus) | 6480464 | Acetaminophen affects the expression of BLCAP mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | Blcap (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of BLCAP mRNA | CTD | PMID:33387578 | parathion | decreases expression | ISO | Blcap (Mus musculus) | 6480464 | Parathion results in decreased expression of BLCAP mRNA | CTD | PMID:34813904 | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of BLCAP mRNA | CTD | PMID:19159669 | phenol | decreases expression | EXP | | 6480464 | Phenol results in decreased expression of BLCAP mRNA | CTD | PMID:17547211 | resorcinol | increases expression | EXP | | 6480464 | resorcinol results in increased expression of BLCAP mRNA | CTD | PMID:22623647 | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of BLCAP mRNA | CTD | PMID:23557933 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of BLCAP mRNA | CTD | PMID:33512557 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BLCAP mRNA | CTD | PMID:27188386 | sodium arsenite | affects expression | EXP | | 6480464 | sodium arsenite affects the expression of BLCAP mRNA | CTD | PMID:29319823 | temozolomide | decreases expression | EXP | | 6480464 | Temozolomide results in decreased expression of BLCAP mRNA | CTD | PMID:31758290 | tetrachloromethane | increases expression | ISO | Blcap (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of BLCAP mRNA | CTD | PMID:31150632 | tetrachloromethane | increases expression | ISO | Blcap (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of BLCAP mRNA | CTD | PMID:31919559 | thioacetamide | increases expression | ISO | Blcap (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of BLCAP mRNA | CTD | PMID:34492290 | trichloroethene | increases methylation | ISO | Blcap (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased methylation of BLCAP gene | CTD | PMID:27618143 | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of BLCAP mRNA | CTD | PMID:26272509 | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BLCAP mRNA | CTD | PMID:27188386 | triclosan | decreases expression | EXP | | 6480464 | Triclosan results in decreased expression of BLCAP mRNA | CTD | PMID:30510588 | triptonide | increases expression | ISO | Blcap (Mus musculus) | 6480464 | triptonide results in increased expression of BLCAP mRNA | CTD | PMID:33045310 | valproic acid | affects expression | ISO | Blcap (Mus musculus) | 6480464 | Valproic Acid affects the expression of BLCAP mRNA | CTD | PMID:17963808 | vinclozolin | affects expression | ISO | Blcap (Rattus norvegicus) | 6480464 | vinclozolin affects the expression of BLCAP mRNA | CTD | PMID:19015723 | vorinostat | decreases expression | EXP | | 6480464 | vorinostat results in decreased expression of BLCAP mRNA | CTD | PMID:27188386 | |